Faecal calprotectin and lactoferrin as markers for monitoring disease activity and predicting clinical recurrence in patients with Crohn's disease after ileocolonic resection: A prospective pilot study.
about
Optimal delivery of follow-up care after surgery for Crohn's disease: current perspectivesRelevance of fecal calprotectin and lactoferrin in the post-operative management of inflammatory bowel diseasesFecal calprotectin in inflammatory bowel diseaseDisease monitoring in inflammatory bowel diseaseComparisons between myeloperoxidase, lactoferrin, calprotectin and lipocalin-2, as fecal biomarkers of intestinal inflammation in malnourished children.Fecal calprotectin correlated with endoscopic remission for Asian inflammatory bowel disease patients.Serial monitoring of faecal calprotectin for the assessment of endoscopic recurrence in asymptomatic patients after ileocolonic resection for Crohn's disease: a long-term prospective study.Illness perceptions and stress: mediators between disease severity and psychological well-being and quality of life among patients with Crohn's diseaseDiagnosis and monitoring of postoperative recurrence in Crohn's disease.The clinical value of faecal calprotectin and lactoferrin measurement in postoperative Crohn's disease.C-Reactive Protein, Fecal Calprotectin, and Stool Lactoferrin for Detection of Endoscopic Activity in Symptomatic Inflammatory Bowel Disease Patients: A Systematic Review and Meta-Analysis.Clinical Utility of Biomarkers in IBD.Monitoring and detection of disease recurrence after resection for Crohn's disease: the role of non-invasive fecal biomarkers.Utility of surrogate markers for the prediction of relapses in inflammatory bowel diseases.Fecal biomarkers in inflammatory bowel disease: how, when and why?Faecal biomarkers for screening small bowel inflammation in patients with Crohn's disease: a prospective study.Fecal calprotectin for evaluating postoperative recurrence of Crohn's disease: a meta-analysis of prospective studies.Efficacy of noninvasive evaluations in monitoring inflammatory bowel disease activity: A prospective study in China.The Value of Fecal Markers in Predicting Relapse in Inflammatory Bowel Diseases.Letter: faecal calprotectin for the prediction of relapse in inactive inflammatory bowel disease.Correlation Between Calprotectin and Modified Rutgeerts Score.Expert opinion for use of faecal calprotectin in diagnosis and monitoring of inflammatory bowel disease in daily clinical practiceFecal calprotectin one year after ileocaecal resection for Crohn's disease--a comparison with findings at ileocolonoscopyFrom bench to bedside: Fecal calprotectin in inflammatory bowel diseases clinical setting
P2860
Q26740356-128EE1C4-9596-4EF4-A863-02285D7375B8Q26750230-70736D79-D48E-4895-9264-21BC0FC32050Q26766527-C755FF6C-196E-4D7A-95E4-EDF58CD1D3F0Q26777553-ACC24A8C-FA49-4152-98F0-D433A71CE92FQ30275717-6635D019-439F-4AA2-AA12-9B7B1708DE3EQ36401625-7BE0D3AE-6B88-4C76-BE37-2CD656852C56Q37173743-2661595F-3707-4A71-BFAB-B788722E174CQ37446446-EFC6725A-5FB2-4D38-A945-74CB147AE126Q38230312-6CAA32F7-C6EC-4F5B-ADD7-648B666B0A37Q38344883-827DCF18-82E6-45D7-90C3-0D9710EA4990Q38474301-97323AEA-F202-4B6F-AF62-36559F3F0FD9Q38539968-C48ADBD0-AEA9-423A-BC5E-8A6676E1CB3FQ38657630-47C426A6-AE79-495A-B48C-C0AFBCC27B19Q38774391-A71EBA83-A206-41E5-BFCC-EBFE93031E3BQ38918650-D231A9E3-FD01-429A-BA90-A50D61B48277Q41407071-F0B27D8C-CC98-403B-A888-451C67AA4DD5Q41608430-77D992C5-A67B-4DDB-AB6D-A87C385BA438Q47100161-43C97FAB-857A-496A-9BC5-69A22344F69EQ49300617-1C06D9DC-066D-45A5-A675-36638EB9A06BQ51534311-8A95708A-1DB8-44BB-9ED0-3DB04144A5D2Q52983772-15F804E6-24B1-4BEF-BBF3-E6EB4572D9A7Q57063313-B1DABCBA-9AFF-47CB-90F6-44496CC7850FQ57109774-22FCE2FB-7747-49D4-93AF-3050CBA2FF98Q58760402-EA2B3565-A403-4ED5-BD40-FEB1ED61AE02
P2860
Faecal calprotectin and lactoferrin as markers for monitoring disease activity and predicting clinical recurrence in patients with Crohn's disease after ileocolonic resection: A prospective pilot study.
description
2013 nî lūn-bûn
@nan
2013 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Faecal calprotectin and lactof ...... on: A prospective pilot study.
@ast
Faecal calprotectin and lactof ...... on: A prospective pilot study.
@en
type
label
Faecal calprotectin and lactof ...... on: A prospective pilot study.
@ast
Faecal calprotectin and lactof ...... on: A prospective pilot study.
@en
prefLabel
Faecal calprotectin and lactof ...... on: A prospective pilot study.
@ast
Faecal calprotectin and lactof ...... on: A prospective pilot study.
@en
P2093
P2860
P356
P1476
Faecal calprotectin and lactof ...... ion: A prospective pilot study
@en
P2093
Koichi Matsumoto
Manabu Shiraki
Satoru Umegae
Takuya Bamba
P2860
P304
P356
10.1177/2050640613501818
P577
2013-10-01T00:00:00Z